Raw Material Acceptance Criteria
Test |
Method / Pharmacopeia |
Specification |
Physical Identity of product | Visual | Report Results |
Foreign matter inspection | Microscopy | Absence of foreign materials |
EP<2.8.2> | ||
Total Moisture Content | Loss on drying USP <921> | Report Results |
EP< 2.2.32> | ||
Total Delta -9- Tetrahydrocannabinol (THC) content | High Pressure Liquid Chromatography (HPLC) | Report results |
Total Cannabidiol (CBD) | High Pressure Liquid Chromatography (HPLC) | Report results |
Pesticides | Health Canada Protocol | Health Canada Limits per the Cannabis Act |
Arsenic | EPA 200.2 / US EPA 200.8 / EP 2.4.20 | <1.96 ppm |
USP <232><233> | <1.96 ppm | |
Mercury | EPA 200.2 / US EPA 200.8 / EP 2.4.20 | < 0.1 ppm |
USP <232><233> | <4.06 ppm | |
Lead | EPA 200.2 / US EPA 200.8 / EP 2.4.20 | < 5.0 ppm |
USP <232><233> | <1.96 ppm | |
Cadmium | EPA 200.2 / US EPA 200.8 / EP 2.4.20 | < 1.0 ppm |
USP <232><233> | <1.26 ppm | |
Aflatoxins (B1+B2+G1+G2) | EP <2.8.18> | < 4 ppb |
USP <2021> | < 20 ppb | |
Aflatoxin B1A | EP <2.8.18> | <2 ppb |
USP <561> | < 5 ppb | |
Total Aerobic Count | EP <2.6.12> | < 500,000 CFU/g |
USP <2021> / USP <61> | <100,000 CFU/g | |
Total Yeasts and Mold count | EP <2.6.12> | < 50,000 CFU/g |
USP <2021>/ USP <61> | <1000 CFU/g | |
Bile Tolerant bacteria | EP <2.6.31> / EP <2.6.13> | < 10,000 MPN/g |
USP <2021>/ USP <61> | < 1,000 MPN CFU/g | |
Escherichia coli | EP <2.6.31> / EP <2.6.13> | Absent in 1g |
USP <2022>/ USP <62> | Absent in 10g | |
Salmonella species | EP <2.6.31> / EP <2.6.13> | Absent in 25g |
USP <2022> / USP <62> | Absent in 10g |